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S U M M A R Y
Objectives: Studies on the association between obesity and the risk of urinary tract infection (UTI) show
inconsistent results. The aim of this study was to determine whether there is any association between
obesity and recurrent UTIs (RUTIs) among premenopausal women.
Methods: A retrospective case–control study was conducted in the outpatient clinics of the internal
medicine departments of three hospitals. All consecutive non-pregnant premenopausal women aged
20–55 years, who presented with RUTIs over a 2-year period, were included; these women were
compared to randomly selected women from the same outpatient clinics who had no history of RUTI and
were age-matched 5 years. RUTI was deﬁned as a symptomatic UTI that followed the resolution of a
previous UTI, or three or more symptomatic episodes over a 12-month period.
Results: Six hundred and ninety-one premenopausal women with UTI were evaluated during the study
period. A total 122 of 162 subjects with RUTIs were included in this study and compared to 122 control
cases without a history of RUTI. The overall prevalence of RUTIs among the premenopausal women with
UTI was 23.4% (162/691). Approximately half of those with RUTIs were obese. The mean age of women
with RUTIs was 43.8  9 vs. 40  10 years among the controls (p = 0.839). The mean body mass index of
women with RUTIs was signiﬁcantly higher than that of controls: 35  4 vs. 26  3 kg/m2 (p < 0.001).
Multivariate regression analysis showed that obesity was associated with RUTIs in premenopausal women
(odds ratio 4.00, 95% conﬁdence interval 3.2–4.61; p = 0.001).
Conclusions: Obesity was found to be associated with RUTIs in premenopausal women.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Obesity has become a serious and worldwide public health
problem.1–3 Obesity is associated with increasing mortality and
morbidity from a variety of diseases including hypertension,
diabetes mellitus, dyslipidemia, metabolic syndrome, cardiovascular
disease, and stroke.4–6 Recently, several studies have shown obesity
to be associated with infections. A retrospective study showed that
obesity is an independent predictor of blood stream infection.7Other
previous studies have shown a correlation between obesity and
septic shock, ventilator-associated pneumonia,8 catheter-associated* Corresponding author. Tel.: +972 4 602 8851; fax: +972 74 755 9051.
E-mail address: w.nseir@yahoo.com (W. Nseir).
http://dx.doi.org/10.1016/j.ijid.2015.10.014
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).sepsis,9 H1N1 inﬂuenza infection,10 and Clostridium difﬁcile infec-
tion.11Moreover, obesity may alter the course of infection and seems
to contribute to the progression of some chronic viral infections such
as hepatitis C.12–14
Urinary tract infection (UTI) is one of the most commonly
acquired bacterial infections in ambulatory and hospitalized
populations. Approximately 11% of all women aged 18 years in
the USA have a UTI each year. The incidence of UTI is highest
among women aged 18–24 years, approaching one of ﬁve
infections per year.15 Among healthy women aged 18–39 years,
the 6-month risk of recurrence following a ﬁrst UTI is 24%.16
Approximately 5% of women with an initial UTI have multiple
episodes within a year. A recent large cohort study indicated that
obesity is a risk factor for UTI.17 As regards pyelonephritis, obese
persons were nearly ﬁve times more likely to be diagnosed thanciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Clinical and biochemical characteristics of the study subjects
Cases with
RUTIs
(n = 122)
Controls
(n = 122)
p-Value
Age, years, mean  SD 43  9 40  10 0.839
Maternal history of RUTIs,
n (%)
21 (17.2) 4 (3.2) <0.05
Use of contraceptives, n (%) 15 (12.3) 12 (9.8) 0.322
Use of probiotics, n (%) 5 (4.1) 19 (15.6) <0.05
Sexual intercourse, n (%) 65 (53.2) 70 (57.4) 0.522
Diabetes mellitus, n (%) 8 (6.5) 9 (7.4) 0.632
Metabolic syndrome, n (%) 13 (10.6) 10 (8.2) 0.784
BMI, kg/m2, mean  SD 35  4 26  3 <0.001
RUTIs, recurrent urinary tract infections; SD, standard deviation; BMI, body mass
index.
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recent retrospective study performed in Israel using a computer-
ized database showed that obesity is independently associated
with UTIs particularly in males.18 Against this background, the
present retrospective study was conducted in order to examine
whether there is any association between obesity and RUTIs in
premenopausal women.
2. Materials and methods
2.1. Subjects
Consecutive premenopausal women with RUTIs who presented
between June 2012 and May 2014 at the outpatient clinics of the
internal medicine departments of three hospitals in Israel (EMMS,
The Nazareth Hospital, Nazareth; The Holy Family Hospital,
Nazareth; Ziv Medical Centre, Safed), who were each followed
up for at least 1 year, were aged 20–55 years, and did not receive
antibiotic prophylaxis for RUTIs, were included in this study. The
following exclusion criteria were applied: pregnant women,
postmenopausal women, women with a malignancy and a life
expectancy of less than 1 year, those with an HIV infection, those
using cranberry juice, the presence of a permanent urinary
catheter, urinary tract stent, or nephrostomy tube, those with
urinary incontinence, neurogenic bladder, asymptomatic bacteri-
uria, sexually transmitted diseases, connective tissue diseases,
kidney malformations, kidney stones, or organ transplant, the
chronic use of corticosteroid therapy, and substance abusers.
Control cases (premenopausal women) were selected randomly
from the same outpatient clinics using the same exclusion criteria;
they were age-matched 5 years and were without a medical
history of RUTI. The study was approved by each hospital review
board. The data were coded to maintain patient anonymity. The need
for informed consent was waived because of the non-interventional
study design.
2.2. Study design
This was a retrospective study, conducted in outpatient clinics
of the internal medicine departments of three hospitals, which
aimed to examine the association between obesity and RUTIs in
premenopausal women. A comparison was made between
premenopausal women with and without RUTIs in term of
maternal history of RUTIs, use of contraceptives, use of probiotics,
sexual intercourse, diabetes mellitus, metabolic syndrome, and
obesity.
2.3. Clinical and laboratory data
Data were obtained from the charts of all patients enrolled.
The following information was extracted: demographic char-
acteristics, anthropometric measures, underlying diseases such
as diabetes mellitus, hypertension, and hyperlipidemia, and
maternal history of RUTIs. In addition, information on drug
therapy, the use of contraceptives, sexual intercourse, use of
probiotics, and the results of laboratory analyses, including
urinalysis and urine cultures, were collected from the medical
charts. Any covariate in the medical information or laboratory
analysis that was not noted as present was considered to be
absent.
2.4. Deﬁnitions
UTI was deﬁned by clinical signs of dysuria and urgency,
frequency of urination, and the presence of fever, chills, and/or loin
pain (pyelonephritis). Bacterial UTI included cystitis, urethritis,and acute pyelonephritis.19 RUTI was deﬁned as a symptomatic UTI
that followed the resolution of a previous UTI, or three or more
symptomatic episodes over a 12-month period.20 All case patients
had to have at least one culture-conﬁrmed UTI. Obesity was
deﬁned as a body mass index (BMI) 30 kg/m2. The diagnosis of
metabolic syndrome was based on the presence of at least three of
the following indices: BMI 30 kg/m2, fasting blood glucose level
>100 mg/dl, serum triglyceride level >150 mg/dl, blood pressure
>135/85 mmHg, and serum high-density lipoprotein (HDL)
cholesterol level <50 mg/dl. This cut-off value for the serum
HDL cholesterol level was based on that recommended by the
National Cholesterol Education Program Adult Treatment Panel
III.21
2.5. Statistical analysis
WinSTAT software (Kalamia, Cambridge, MA, USA) was utilized
for data handling and analysis. Mean values, standard deviations
(SDs), and p-values were calculated. The two groups of premeno-
pausal women with and without RUTIs were compared in terms of
maternal history of RUTIs, use of contraceptives, use of probiotics,
sexual intercourse, diabetes mellitus, metabolic syndrome, and
BMI. Categorical variables were compared with the Chi-square test
and continuous variables with the Student t-test. Spearman rank
correlation and univariate regression analysis were used to
determine the strength of the relationship between the different
risk factors including BMI and RUTIs. A risk factor associated with a
p-value of <0.05 in the univariate analysis was used for further
analysis. Multivariate regression analysis was performed to
determine the association between the risk factors and RUTIs.
Statistical signiﬁcance was set at 5%.
3. Results
Six hundred and ninety-one premenopausal women with UTI
were evaluated during the study period, 162 of whom had RUTIs.
Of these, 40 were excluded: nine subjects had kidney stones, eight
had sexually transmitted diseases, seven were pregnant, six were
on cranberry juice, ﬁve were on antibiotic prophylaxis, three had a
neurogenic bladder, and two had a malignancy. Finally, 122 pre-
menopausal women with RUTIs were eligible for analysis
following the application of the study inclusion and exclusion
criteria. The overall prevalence of RUTI among premenopausal
women was 23.4% (162/691). Approximately half of those with
RUTIs (49.5%) were obese. The mean number of diagnosed episodes
of UTI was 3.9  0.4 per year. Table 1 shows the clinical and
laboratory parameters of the cases with and without RUTIs. No
signiﬁcant difference was found between cases and controls in terms
of age, the use of contraceptives, sexual intercourse, diabetes mellitus,
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in maternal history of RUTIs, the use of probiotics, and obesity
between the RUTI cases and controls.
Table 2 shows the results of multivariate regression analysis: a
maternal history of RUTIs (odds ratio (OR) 1.6, 95% conﬁdence
interval (CI) 1.2–2.0; p = 0.05), no use of probiotics (OR 1.90, 95% CI
1.21–2.4; p = 0.05), and a BMI >30 kg/m2 (OR 4.0, 95% CI 3.2–4.61;
p = 0.001) were associated with RUTIs in premenopausal women.
4. Discussion
In this retrospective case–control study, obesity was found to
be associated with RUTIs in premenopausal women. To the
authors’ knowledge, this is the ﬁrst study evaluating the
association between obesity and RUTIs in premenopausal women.
The mechanisms underlying the association between obesity
and infection are the subject of ongoing research. Obesity is
associated with a variety of diseases, including metabolic
syndrome and non-alcoholic fatty liver disease.4,6,22,23 Obesity-
related system dysregulation, decreased cell-mediated immune
responses, and respiratory dysfunction have been proposed as
possible mechanisms.24–26 The most important immunomodula-
tory adipokines in obesity are leptin, adiponectin, and the pro-
inﬂammatory cytokines tumor necrosis factor alpha (TNF-a),
interleukin (IL)-6, and IL-1b.27 Low levels of adiponectin in obesity
have been shown to alter the immune response, especially killer
cell cytotoxicity and cytokine production by human myeloid
cells.28
Lactobacilli are the dominant bacteria of the vaginal ﬂora and
possess antimicrobial properties that regulate the urogenital
microbiota. Inadequate cure and recurrence of genitourinary
infections lead to a shift in the urogenital ﬂora from a
predominance of lactobacilli to coliform uropathogens. Therefore,
the use of lactobacillus-containing probiotics to restore the
commensal urogenital ﬂora has been proposed for the treatment
and prophylaxis of RUTIs.29,30 A recent meta-analysis on the use of
Lactobacillus in the prevention of RUTIs in women showed that
probiotics are safe and effective in preventing RUTIs.31 In the
present study, the use of probiotics was shown to be effective in
the prevention of RUTIs, as has been reported by the authors in a
previous publication.32 However, there is a need for more
randomized controlled trials assessing the use of probiotics in
UTIs.
Another ﬁnding of this study was the association between
maternal history of UTI and RUTIs. Several previous studies have
shown that a history of UTI in the mother is associated with 2–3-
fold increased risk of UTI in her daughters.33,34 This risk factor
could reﬂect other shared environmental factors, or behaviors
present in both mothers and daughters. The genetic contribution in
UTI has been studied in several studies.35,36 The authors believe
that more genetic studies are needed in order to evaluate this
association.
This study has several limitations, being a retrospective study
with a relatively small number of cases.Table 2
Multivariate regression analysis showing the independent associations of body
mass index and RUTIs in premenopausal women
OR (95% CI) p-Value
Maternal history of RUTIs 1.60 (1.2–2.0) 0.05
No use of probiotics 1.90 (1.21–2.4) 0.05
BMI >30 kg/m2 (obesity) 4.00 (3.2–4.61) 0.001
RUTIs, recurrent urinary tract infections; OR, odds ratio; CI, conﬁdence interval;
BMI, body mass index.In conclusion, this study provides evidence that obesity could
be associated with RUTIs in premenopausal women. However,
prospective studies are required to assess this association and
whether a reduction in weight will prevent the occurrence of UTIs/
RUTIs.
Conﬂict of interest: The authors declare that they have no
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